Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Oxford Nanopore Technologies PLC ( (GB:ONT) ) is now available.
Oxford Nanopore Technologies has reported routine employee share dealings under its Share Incentive Plan involving its chief executive officer, Francis Van Parys, and chief financial officer, Nick Keher. Both directors purchased 136 partnership shares each at £1.10 per share via the plan’s trustee, Computershare Trustees Limited, using their gross salary contributions.
In line with the plan’s terms, the company issued a further 136 matching shares for each director, which are held on their behalf by the trustee at no additional cost. The transactions, conducted on 14 April 2026 on the London Stock Exchange, marginally increase the executives’ equity stakes and reflect ongoing alignment of senior management incentives with shareholder interests under the UK Market Abuse Regulation disclosure regime.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £1.72 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Spark’s Take on ONT Stock
According to Spark, TipRanks’ AI Analyst, ONT is a Neutral.
The score is held back primarily by weak financial performance—large ongoing losses and continued cash burn—despite improving revenue growth and solid gross margins. Technicals also detract due to a clear downtrend (below major moving averages and negative MACD). Offsetting factors include constructive earnings-call guidance with margin/OpEx discipline and a credible longer-term breakeven timeline, plus a relatively low-leverage balance sheet.
To see Spark’s full report on ONT stock, click here.
More about Oxford Nanopore Technologies PLC
Oxford Nanopore Technologies plc is a UK-based life sciences company specialising in nanopore-based sequencing technologies used for DNA and RNA analysis. Its products serve research, clinical, and applied markets that require real-time, scalable sequencing and genomic insights.
Average Trading Volume: 1,841,542
Technical Sentiment Signal: Sell
Current Market Cap: £1.05B
For detailed information about ONT stock, go to TipRanks’ Stock Analysis page.

